A comprehensive view of f. hoffmann-la roche ltd. (roche). This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

F. Hoffmann-La Roche Ltd. Champions Women's Health and Disability Independence, Aiming to Add 500 Healthier Days and Promote Gender Equality in Leadership
Published: April 26, 2024 by Industry Intelligence Inc.
CHMP recommends EU approval of Roche’s Alecensa monotherapy as the first adjuvant treatment for resected ALK-positive early-stage lung cancer; about half of people living with early-stage NSCLC experiencing disease recurrence or death following surgery
Published: April 26, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
Roche reports group sales increase by 2% year-over-year due to the success of newer medicines and diagnostics, independent of COVID-19 products; the surge was offset by the strengthening of the Swiss franc and a decline in COVID-19 test demand
Published: April 24, 2024 by F. Hoffmann-La Roche Ltd. (Roche)
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, ROCHE DIABETES CARE GMBH, ROCHE DIABETES CARE, INC. FILES APPLICATION FOR "FILLING APPARATUS AND METHOD FOR FILLING A REUSABLE RESERVOIR OF A MEDICAL DISPENSING DEVICE"
Published: April 20, 2024 by U.S. Fed News
INTERNATIONAL PATENT: F. HOFFMANN-LA ROCHE AG, HOFFMANN-LA ROCHE INC. FILES APPLICATION FOR "ANTIVIRAL COMPOUNDS"
Published: April 20, 2024 by U.S. Fed News

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count